UK PROSPECTIVE DIABETES STUDY (UKPDS) .14. ASSOCIATION OF ANGIOTENSIN-CONVERTING ENZYME INSERTION DELETION POLYMORPHISM WITH MYOCARDIAL-INFARCTION IN NIDDM/
Bd. Keavney et al., UK PROSPECTIVE DIABETES STUDY (UKPDS) .14. ASSOCIATION OF ANGIOTENSIN-CONVERTING ENZYME INSERTION DELETION POLYMORPHISM WITH MYOCARDIAL-INFARCTION IN NIDDM/, Diabetologia, 38(8), 1995, pp. 948-952
Citations number
16
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
The deletion allele of the insertion/deletion polymorphism of the angi
otensin-converting enzyme gene has been suggested to be an independent
risk factor for myocardial infarction, particularly in subjects judge
d to be ''low-risk'' by the criteria of lipid status and body mass ind
ex. In a prospective, matched case-control study, we have investigated
the role of this polymorphism as a risk factor for myocardial infarct
ion in 173 newly-diagnosed British Caucasian non-insulin-dependent dia
betic subjects taken from the United Kingdom Prospective Diabetes Stud
y who subsequently developed myocardial infarction and 297 control sub
jects from the same study population matched for known cardiovascular
risk factors including age at diagnosis of diabetes, gender, blood pre
ssure, low-density lipoprotein cholesterol, high-density lipoprotein c
holesterol, triglyceride and smoking habit. A trend towards increased
risk conferred by homozygosity for the deletion allele was observed in
cases (odds ratio 1.63, p = 0.09). When the population was stratified
according to the matched risk factors, the deletion allele was associ
ated with myocardial infarction in those with low plasma low-density l
ipoprotein cholesterol (odds ratio 3.67, p = 0.002), or low triglyceri
de (odds ratio 3.14, p = 0.005). The strongest association of the dele
tion allele with myocardial infarction was observed in subjects with b
oth low low-density lipoprotein cholesterol and low triglyceride level
s (odds ratio 9.0, p < 0.001). These results show that the deletion al
lele is a risk factor for myocardial infarction in non-insulin-depende
nt diabetic patients who have a favourable lipid profile.